Login to Your Account



Prima deal shuttles its cancer vaccine candidate to Seattle

By Michael Fitzhugh
Staff Writer

Thursday, May 12, 2016

Prima Biomed Ltd.'s quest to divest its one-time lead program, Cvac, has ended with the cell therapy's adoption by biotech entrepreneur Joseph Hernandez, who will carry it ahead under the banner of Sydys Corp.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription